JEISYS MEDICAL INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,450 KRW | +0.85% |
|
-21.38% | -9.91% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jeisys Medical Inc, formerly Yuanta 3 Special Purpose Acquisition Co Ltd, a Korea-based company principally engaged in the manufacturing and distribution of medical devices. The Company manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
9,450
KRW
Average target price
14,038
KRW
Spread / Average Target
+48.54%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.91% | 518M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- A287410 Stock
- News Jeisys Medical Inc.
- Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China
